Resource ValueSet/FHIR Server from package rki.demis.disease#2.0.1 (46 ms)
Package | rki.demis.disease |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | https://demis.rki.de/fhir/demis/https://simplifier.net/resolve?scope=rki.demis.disease@2.0.1&canonical=https://demis.rki.de/fhir/ValueSet/vaccineCVDD-SNOMED |
Url | https://demis.rki.de/fhir/ValueSet/vaccineCVDD-SNOMED |
Version | 1.3.0 |
Status | active |
Date | 2024-09-03 |
Name | VaccineCVDD-SNOMED |
Title | Covid-19-Impfstoff als SNOMED-Code |
Experimental | False |
Description | Das ValueSet VaccineCVDD-SNOMED enthält die Codes der Covid-19-Impfstoffe als SNOMED-Code. |
Copyright | This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. “SNOMED” and “SNOMED CT” are registered trademarks of the IHTSDO.
Dieses Material enthält SNOMED Clinical Terms® (SNOMED CT®), die mit Genehmigung der International Health Terminology Standards Development Organisation (IHTSDO) verwendet werden. Alle Rechte vorbehalten. SNOMED CT® wurde ursprünglich vom College of American Pathologists entwickelt. "SNOMED" und "SNOMED CT" sind eingetragene Warenzeichen der IHTSDO.
Downloadbedingungen für SNOMED-CT
Enthält durch SNOMED International urheberrechtlich geschützte Information. Jede Verwendung von SNOMED CT in Deutschland erfordert eine vollgültige Affiliate Lizenz oder eine Sublizenz. Die entsprechende Lizenz ist kostenlos, vorausgesetzt die Verwendung findet nur in Deutschland statt und erfüllt die Bedingungen des Affiliate License Agreements. Affiliate Lizenzen können über das Mitglieder-Lizenzierungs- und Distributions-Service (MLDS) direkt beim jeweiligen NRC beantragt werden. https://mlds.ihtsdotools.org/#/landing/DE?lang=de
Contains information protected by copyright of SNOMED International. Any use of SNOMED CT in Austria requires a valid affiliate license or sublicense. The corresponding license is free of charge, provided that the use only takes place in Austria and fulfills the conditions of the Affiliate License Agreement. Affiliate licenses can be requested directly from the respective NRC via the Member Licensing and Distribution Service (MLDS). ttps://mlds.ihtsdotools.org/#/landing/DE?lang=de |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "vaccineCVDD-SNOMED",
"url" : "https://demis.rki.de/fhir/ValueSet/vaccineCVDD-SNOMED",
"version" : "1.3.0",
"name" : "VaccineCVDD-SNOMED",
"title" : "Covid-19-Impfstoff als SNOMED-Code",
"status" : "active",
"experimental" : false,
"date" : "2024-09-03",
"publisher" : "Robert Koch-Institut",
"description" : "Das ValueSet VaccineCVDD-SNOMED enthält die Codes der Covid-19-Impfstoffe als SNOMED-Code.",
"copyright" : "This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. âSNOMEDâ and âSNOMED CTâ are registered trademarks of the IHTSDO.\r\n\r\nDieses Material enthält SNOMED Clinical Terms® (SNOMED CT®), die mit Genehmigung der International Health Terminology Standards Development Organisation (IHTSDO) verwendet werden. Alle Rechte vorbehalten. SNOMED CT® wurde ursprünglich vom College of American Pathologists entwickelt. \"SNOMED\" und \"SNOMED CT\" sind eingetragene Warenzeichen der IHTSDO.\r\n\r\nDownloadbedingungen für SNOMED-CT\r\n\r\nEnthält durch SNOMED International urheberrechtlich geschützte Information. Jede Verwendung von SNOMED CT in Deutschland erfordert eine vollgültige Affiliate Lizenz oder eine Sublizenz. Die entsprechende Lizenz ist kostenlos, vorausgesetzt die Verwendung findet nur in Deutschland statt und erfüllt die Bedingungen des Affiliate License Agreements. Affiliate Lizenzen können über das Mitglieder-Lizenzierungs- und Distributions-Service (MLDS) direkt beim jeweiligen NRC beantragt werden. https://mlds.ihtsdotools.org/#/landing/DE?lang=de\r\n\r\nContains information protected by copyright of SNOMED International. Any use of SNOMED CT in Austria requires a valid affiliate license or sublicense. The corresponding license is free of charge, provided that the use only takes place in Austria and fulfills the conditions of the Affiliate License Agreement. Affiliate licenses can be requested directly from the respective NRC via the Member Licensing and Distribution Service (MLDS). ttps://mlds.ihtsdotools.org/#/landing/DE?lang=de",
"compose" : {
"include" : [
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/11000274103/version/20240515",
"concept" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 16
}
],
"code" : "1119349007",
"display" : "COVID-19-Impfstoff (mRNA) (BioNTech / Pfizer, Moderna)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 10
}
],
"code" : "1157024006",
"display" : "COVID-19-Impfstoff (Virusimpfstoff, inaktiviert, adjuvantiert) (Valneva)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 12
}
],
"code" : "1162643001",
"display" : "COVID-19-Impfstoff (Proteinbasierter Impfstoff, rekombinant, adjuvantiert) (Sanofi - GSK)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 13
}
],
"code" : "1187593009",
"display" : "COVID-19-Impfstoff (Proteinbasierter Impfstoff) (Novavax)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 14
}
],
"code" : "1287595003",
"display" : "COVID-19-Impfstoff (mRNA), bivalent, pädiatrisch (BioNTech / Pfizer, Moderna)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Pediatric vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 15
}
],
"code" : "1287596002",
"display" : "COVID-19-Impfstoff (mRNA), bivalent (BioNTech / Pfizer, Moderna)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 11
}
],
"code" : "29061000087103",
"display" : "COVID-19-Impfstoff (Vektor-Impfstoff) (Astra Zeneca, Johnson&Johnson bzw. Janssen-Cilag)",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)"
}
]
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-conceptOrder",
"valueInteger" : 1
}
],
"code" : "74964007",
"display" : "andere/sonstige",
"designation" : [
{
"language" : "en-US",
"use" : {
"system" : "http://snomed.info/sct",
"code" : "900000000000003001"
},
"value" : "Other (qualifier value)"
}
]
}
]
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.